Enovis to Participate in Investor Conferences in September

Wilmington, DE, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences in September.

• 2022 Wells Fargo Healthcare Conference on Wednesday, September 7^th in Boston, MA: participating in the conference will be Matt Trerotola, CEO, and Ben Berry, CFO of the Company’s business units who will succeed Chris Hix as Enovis Chief Financial Officer on January 1, 2023.
• Baird 2022 Global Healthcare Conference on Wednesday, September 14^th in New York, NY: participating in the conference will be Matt Trerotola, CEO and Chris Hix, CFO.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Contact:

Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-252-9159
[email protected]

***

Source: Enovis Corporation

You May Also Be Interested In

• QNB Corp. Announces Exercise of Overallotment Option of 160,714 Shares of Common Stock
• Dillard’s, Inc. Announces $0.30 Cash Dividend
• Diego Reynoso to join Ingredion as Chief Financial Officer